- The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
-
Varbobitis I, Papatheodoridis GV
- KMID: 2373131
- Clin Mol Hepatol.
- 2016 Sep;22(3):319-326.
- doi: 10.3350/cmh.2016.0045
Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting... -
- CITED
-
- Close
- SHARE
-
- Close
